4-iodo-2,5-dimethoxyphenylisopropylamine has been researched along with Idiopathic Parkinson Disease in 3 studies
4-iodo-2,5-dimethoxyphenylisopropylamine: RN given refers to unlabeled parent cpd without isomeric designation; a serotonin agonist
2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine : An organoiodine compound that is amphetamine bearing two methoxy substituents at positions 2 and 5 as well as an iodo substituent at position 4.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrzejewski, K | 1 |
KaczyĆska, K | 1 |
Zaremba, M | 1 |
Wang, S | 1 |
Zhang, QJ | 1 |
Liu, J | 1 |
Ali, U | 1 |
Wu, ZH | 1 |
Chen, L | 1 |
Gui, ZH | 1 |
Wang, Y | 1 |
Hui, YP | 1 |
McFarland, K | 1 |
Price, DL | 1 |
Bonhaus, DW | 1 |
3 other studies available for 4-iodo-2,5-dimethoxyphenylisopropylamine and Idiopathic Parkinson Disease
Article | Year |
---|---|
Serotonergic system in hypoxic ventilatory response in unilateral rat model of Parkinson's disease.
Topics: Amphetamines; Animals; Brain Stem; Corpus Striatum; Hypoxia; Ketanserin; Male; Organ Specificity; Ox | 2017 |
In vivo effects of activation and blockade of 5-HT(2A/2C) receptors in the firing activity of pyramidal neurons of medial prefrontal cortex in a rodent model of Parkinson's disease.
Topics: Action Potentials; Amphetamines; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; | 2009 |
Pimavanserin, a 5-HT2A inverse agonist, reverses psychosis-like behaviors in a rodent model of Parkinson's disease.
Topics: Amphetamine; Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Central Nervous System S | 2011 |